U.S. market Closed. Opens in 11 hours 16 minutes

PAHC | Phibro Animal Health Corporation Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for PAHC we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is unacceptably poor, Growth is bad and Health is passable.

Valuation (48%)

Company Industry
P/E Ratio (TTM) 366.35 24.50
PEG Ratio (TTM) 58.53 2.33
P/S Ratio (TTM) 0.88 5.42
P/B Ratio (TTM) 3.47 5.06
P/FCF Ratio (TTM) 19.21 11.26
Price to 5YR AVG Earnings Ratio 19.83 5.17
Price to 5YR AVG FCF Ratio 95.23 23.99

Profitability (25%)

Company Industry
ROA (TTM) 0.25% 3.20%
ROE (TTM) 0.91% 31.38%
Net Profit Margin (TTM) 0.24% -10.10%
ROIC 5YR AVG 7.89% 10.85%

Growth (42%)

4QTR AVG 3YR AVG 5YR AVG
EPS 105.48% 4.41% -22.50%
Revenue 1.96% 4.62% 4.34%
Net Income 103.76% 4.62% -22.49%
Cash Flow 40.05% -9.09% 94.58%

Health (51%)

Company Industry
Current Ratio (TTM) 2.94 2.49
Quick Ratio (TTM) 1.64 1.83
D/E Ratio (TTM) 1.93 -0.01
Interest Coverage (TTM) 2.26 12.09
Piotroski F-Score 8 6
Altman Z-Score 2.71 4.74
LTL to 5YR AVG FCF 49.00 4.47
Shares Outstanding Growth 5YR AVG 0.05% 28.76%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙